Cytokine storms: understanding COVID-19

Cited by (703)

Items 301–400 of 703

1. Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity
   Youjun Mi, Lijuan Liang, Kun Xu, Qing Li, Wenting Wang, Wenrui Dang, Jiahui Deng, Yucheng Zhi, Xuefeng Li, Jiying Tan · 2022 · Frontiers in Cellular and Infection Microbiology
2. Association between periodontitis and COVID-19 infection: a two-sample Mendelian randomization study
   Zhaoqiang Meng, Yujia Ma, Wenjing Li, Xuliang Deng · 2023 · PeerJ
3. Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
   Daizee Talukdar, Purbita Bandopadhyay, Yogiraj Ray, Shekhar Ranjan Paul, Jafar Sarif, Ranit D’Rozario, Abhishake Lahiri, Santanu Das, Debaleena Bhowmik, Shilpak Chatterjee et al. · 2023 · Gut Pathogens
4. Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases
   Nisha Gulati, Dinesh Kumar Chellappan, Ronan J. MacLoughlin, Gaurav Gupta, Sachin Kumar Singh, Brian Gregory George Oliver, Kamal Dua, Harish Dureja · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
5. The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer
   Gino M Dettorre, M. Patel, Alessandra Gennari, George E. Pentheroudakis, Emanuela Romano, Alessio Cortellini, David James Pinato · 2021 · ESMO Open
6. Major dietary patterns in relation to disease severity, symptoms, and inflammatory markers in patients recovered from COVID-19
   Armin Ebrahimzadeh, Mohsen Taghizadeh, Alireza Milajerdi · 2022 · Frontiers in Nutrition
7. Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial.
   Iván Delgado‐Enciso, Juan Paz-García, Carlos E Barajas-Saucedo, Karen A Mokay-Ramírez, Carmen Meza‐Robles, Rodrigo Lopez‐Flores, Marina Delgado‐Machuca, Efrén Murillo‐Zamora, Jose A. Toscano-Velazquez, Josuel Delgado‐Enciso et al. · 2020
8. Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department
   Wolfgang Bauer, Jannis Ulke, Noa Galtung, Leonore Claudia Strasser-Marsik, Nick Neuwinger, R Tauber, Rajan Somasundaram, Kai Kappert · 2021 · The Journal of Infectious Diseases
9. Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals
   Subramaniyan Bharathiraja, Jason L. Larabee, Manish Bodas, Andrew R. Moore, Anthony W. G. Burgett, Dean A. Myers, Constantin Georgescu, Jonathan D. Wren, James F. Papin, Matthew S. Walters · 2021 · Viruses
10. Ascorbic acid and IFNγ preconditioning enhance the potency of human mesenchymal stem cells to ameliorate LPS induced cytokine storm
    Avinash Purushottam Sanap, Supriya Mohit Kheur, Avinash Haribhau Kharat, Ramesh Ramachandra Bhonde · 2023 · International Immunopharmacology
11. Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
    Engin Berber, Deepak Sumbria, Barry T. Rouse · 2021 · Microbes and Infection
12. Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4
    Madhavi P. Gavini, Abuzar Mahmood, Anthony M. Belenchia, Paige Beauparlant, Senthil Arun Kumar, Sivakumar Ardhanari, Vincent Gerard DeMarco, Lakshmi Pulakat · 2021 · Frontiers in Pharmacology
13. Adult Still's disease: New horizons
    Evgeny Lvovich Nasonov, Eugen Feist · 2021 · Rheumatology Science and Practice
14. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction
    Rahnuma Ahmad, Mainul Haque · 2022 · Vaccines
15. Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19
    Anna Paola Capra, Lelio Crupi, Giuseppe Pantò, Alberto Repici, Fabrizio Calapai, Raffaele Squeri, Alessio Ardizzone, Emanuela Esposito · 2023 · International Journal of Molecular Sciences
16. Clinical and Radiological Characteristics of Acute Cerebrovascular Diseases Among Egyptian Patients With COVID-19 in Upper Egypt
    Eman Mohamed Khedr, Radwa K. Soliman, Noha Abo Elfetoh, Mariam Taher Amin, Ossama Yassin Mansour, Ahmed Mohamed Aly, Ahmed Fathi Zaki, Mostafa Saber · 2021 · Frontiers in Neurology
17. Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease
    Migiwa Ohgushi, Naruhiko Ogo, Toyoshi Yanagihara, Yukiko Harada, Kosuke Sumida, Ayaka Egashira, Tatsuma Asoh, Takashige Maeyama, Seiji Yoshizawa · 2021 · Internal Medicine
18. Immune Mechanisms of Viral, Autoimmune, and Immune Checkpoint Inhibitor‐Associated Myocarditis
    Wonyoung Jo, Vivian Sun, Daniela Čiháková · 2026 · Immunological Reviews
19. Polydopamine-coated mesoporous silica nanoparticles co-loaded with Ziyuglycoside I and Oseltamivir for synergistic treatment of viral pneumonia
    Hong Wang, Lei Chen, Ruidong Li, Chunmei Lv, Yingshu Xu, Yongai Xiong · 2023 · International Journal of Pharmaceutics
20. Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment
    Maria Luisa Navacchia, Caterina Cinti, Elena Marchesi, Daniela Perrone · 2024 · Molecules
21. SARS-Cov-2 Replication in a Blood–Brain Barrier Model Established with Human Brain Microvascular Endothelial Cells Induces Permeability and Disables ACE2-Dependent Regulation of Bradykinin B1 Receptor
    Sharton Vinícius Antunes Coelho, Gabriela Lisboa e Souza, Bruno Braz Bezerra, Luan Rocha Lima, Isadora Alonso Corrêa, Dalziza Victalina de Almeida, Rodrigo Pacheco Silva-Aguiar, Ana Acácia S. Pinheiro, Pierré Sirois, Celso Caruso‐Neves et al. · 2025 · International Journal of Molecular Sciences
22. Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection
    Amanda J. Lee, Emily Feng, Marianne V. Chew, Elizabeth Balint, Sophie M. Poznanski, Elizabeth C. Giles, Ali Zhang, Art Marzok, Spencer D. Revill, Fatemeh Vahedi et al. · 2022 · PLoS Pathogens
23. Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19
    Morteza Gholaminejhad, Mehdi Forouzesh, Babak Ebrahimi, Seyed Amirhosein Mahdavi, Seyed Davood Mirtorabi, Amirreza Liaghat, Seyed Jalil Monabati, Muhammad Obaid Hamza, Gholamreza Hassanzadeh · 2022 · Journal of Molecular Histology
24. COVID ‐19 and primary wound healing: A new insights and advance
    Danyi Li, Wenjie Cao, Qun Zhou, Xiaomin Wu, Xiayun Song, Haofang Qin · 2023 · International Wound Journal
25. Parámetros hematológicos y biomarcadores predictores de gravedad en Síndrome Inflamatorio Pediátrico Multisistémico asociado a SARS-CoV-2
    Patricia Verdugo, Patricia Álvarez, Patricia Aroca, Vicente Montes, M. Cecilia Poli, Lorena I. Tapia, Fernanda Cofré S., Verónica Soto, Jorge Mackenney P., Cristian Carvajal et al. · 2021 · Andes pediatrica
26. Colchicine, COVID‐19 and hematological parameters: A meta‐analysis
    Musharraf Sarwar, Zahid Ali, Mahnoor Fatima, Zouina Sarfraz, Azza Sarfraz, Iván Chérrez-Ojeda · 2021 · Journal of Clinical Laboratory Analysis
27. Pleural Mesothelial Cells Modulate the Inflammatory/Profibrotic Response During SARS-CoV-2 Infection
    Giulia Matusali, Flavia Trionfetti, Veronica Bordoni, Roberta Nardacci, Laura Falasca, Daniele Colombo, Michela Terri, Claudia Montaldo, Concetta Castilletti, Davide Mariotti et al. · 2021 · Frontiers in Molecular Biosciences
28. Healing Field: Using Alternating Electric Fields to Prevent Cytokine Storm by Suppressing Clonal Expansion of the Activated Lymphocytes in the Blood Sample of the COVID-19 Patients
    Hamed Abadijoo, Mohammad Ali Khayamian, Mahsa Faramarzpour, Mohammadreza Ghaderinia, Hossein Simaee, Shahriar Shalileh, Seyed Mojtaba Yazdanparast, Bahman Ghabraie, Jalil Makarem, Ramin Sarrami‐Forooshani et al. · 2022 · Frontiers in Bioengineering and Biotechnology
29. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation
    Nazar Beirag, Chandan Kumar, Taruna Madan, Mohamed H. Shamji, Roberta Bulla, Daniel A. Mitchell, Valarmathy Murugaiah, Martin Mayora Neto, Nigel James Temperton, Susan Idicula‐Thomas et al. · 2022 · Frontiers in Immunology
30. A living neutrophil Biorobot synergistically blocks multifaceted inflammatory pathways in macrophages to effectively neutralize cytokine storm
    Ya Gao, Anwei Zhou, Kerong Chen, Xinyuan Zhou, Yurui Xu, Shuangshuang Wu, Xinghai Ning · 2023 · Chemical Science
31. Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
    Yixuan Wang, Yan Yao, Qing‐Feng Zhang, Hao Chen, Yang He, Ke Hu · 2024 · BMC Infectious Diseases
32. Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine
    Jessica Gasparello, Chiara Papi, Giovanni Marzaro, Alberto Macone, Matteo Zurlo, Alessia Finotti, Enzo Agostinelli, Roberto Gambari · 2024 · Molecules
33. Enhanced Epigenetic Modulation via mRNA-Encapsulated Lipid Nanoparticles Enables Targeted Anti-inflammatory Control
    Tahere Mokhtari, Mohammad Nasser Taheri, Sarah Akhlaghi, Armin Aryannejad, Yuda Xiang, Vineet Mahajan, Kamyar Keshavarz F., Amirreza Kiani, Samantha Yang, Samuel T. LoPresti et al. · 2026 · ACS Synthetic Biology
34. Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
    Ramona D’Amico, Francesco Lo Monaco, Rosalba Siracusa, Marika Cordaro, Roberta Fusco, Alessio Filippo Peritore, Enrico Gugliandolo, Rosalia Crupi, Salvatore Cuzzocrea, Rosanna Di Paola et al. · 2021 · International Journal of Molecular Sciences
35. Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19
    Malek Zarei, Navideh Sahebi Vaighan, Seyed Ali Ziai · 2021 · Immunopharmacology and Immunotoxicology
36. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19
    Hong Liang, Min He, Shaoping Li, Jing Zhao · 2022 · Chinese Medicine
37. A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19
    Lin Xia, Lunzhi Yuan, Ya-hong Hu, Junyi Liu, Guo-Sheng Hu, Ruoyao Qi, Tian-ying Zhang, Hualong Xiong, Zaozao Zheng, Hong-wei Lin et al. · 2023 · Cellular and Molecular Immunology
38. Mechanism of COVID-19-Induced Cardiac Damage from Patient, In Vitro and Animal Studies
    Elizabeth A. V. Jones · 2023 · Current Heart Failure Reports
39. A meta analysis on the utility of Anakinra in severe COVID-19 disease
    Aliae A. R. Mohamed Hussein, Reem Sayad, Abdelrahman Abdelshafi, Islam Abdelaal Hammam, Ahmed M. Kedwany, Shrouk Alaa-eldein Elkholy, Islam H. Ibrahim · 2023 · Cytokine
40. The Novel Coronavirus and Inflammation
    Jaya A. George, Elizabeth Sarah Mayne · 2021 · Advances in experimental medicine and biology
41. Through DNA sensors and hidden mitochondrial effects of SARS-CoV-2
    Vitor Pedro Targhetta, Mariana Abrantes do Amaral, Niels Olsen Saraiva Câmara · 2021 · The Journal of venomous animals and toxins including tropical diseases
42. Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury
    Smarajit Maiti, Amrita Banerjee, Mehak Kanwar · 2022 · Phytomedicine Plus
43. Are Antisense Long Non-Coding RNA Related to COVID-19?
    Eman A.E. Badr, Ibrahim Eltantawy El Sayed, Mohanad Kareem Razak Alasdi Gabber, Eman Abdel-Rahim Ghobashy, Abdullah Godran Al-Sehemi, H. Algarni, Yasser Elghobashy · 2022 · Biomedicines
44. Changes of Damage Associated Molecular Patterns in COVID-19 Patients
    Xing Fan, Jin‐Wen Song, Siyu Wang, Wenjing Cao, Xiuwen Wang, Ming‐Ju Zhou, Tao Yang, Chun‐Bao Zhou, Jun Hou, Ji‐Yuan Zhang et al. · 2021 · Infectious Diseases & Immunity
45. Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock
    Takeharu Sakamoto, Yuya Fukui, Yasumitsu Kondoh, Kaori Honda, Takeshi Shimizu, Toshiro Hara, Tetsuro Hayashi, Yurika Saitoh, Yoshinori Murakami, Jun‐ichiro Inoue et al. · 2021 · Communications Biology
46. Severe COVID ‐19 correlates with lower mitochondrial cristae density in PBMCs and greater sitting time in humans
    Mauricio Castro‐Sepúlveda, Germán Tapia‐Curimil, Mauro Tuñón‐Suárez, Alejandra Díaz, Hugo Marambio, Mayalen Valero‐Breton, Rodrigo Fernández‐Verdejo, Hermann Zbinden‐Foncea · 2022 · Physiological Reports
47. Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis
    Paolo Gisondi, Davide Geat, Francesco Bellinato, Giampiero Girolomoni · 2022 · Expert Opinion on Biological Therapy
48. A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities
    Avinash D. Khadela, Shruti Soni, Kaivalya Megha, Shivam U. Bhagat, Vivek P. Chavda · 2023 · Biologics
49. Effectiveness of Omega-3 Fatty Acid Supplementation in Improving the Metabolic and Inflammatory Profiles of Mexican Adults Hospitalized with COVID-19
    Diana Rodríguez-Vera, Juan Rodrigo Salazar, Marvin Antonio Soriano-Ursua, Jessica Guzmán-Pérez, Arely Vergara‐Castañeda, Horacio Muñoz Durán, Gabriela Ramírez-Vélez, Alonso Vivar-Sierra, Carlos Rogelio Naranjo-Navarro, Patricia A. Meza-Meneses et al. · 2024 · Diseases
50. Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?
    Rebeca García‐Fandiño, Ángel Piñeiro · 2021 · Frontiers in Immunology
51. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
    Nihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, Birnur Sinem Karaoglan, Khalid Shah, Gürkan Öztürk · 2022 · Cells
52. Recent two-year advances in anti-dengue small-molecule inhibitors
    Chao Yang, Wansheng Xie, Heqian Zhang, Wenjian Xie, Tiantian Tian, Zhiwei Qin · 2022 · European Journal of Medicinal Chemistry
53. Estudo de Caso: Uma Abordagem a partir do Papel do Teólogo para a Comunidade Cristã Evangélica Durante a Pandemia da Covid-19 nos Anos 2020 / 2021
    Jackson Alves da Silva, Leide Daiane Alves da Silva · 2021 · Uniedusul Editora eBooks
54. COVID‐19 and cognitive impairment: From evidence to SARS‐CoV‐2 mechanism
    Haodong Pan, Jingyan Niu, Lin Feng, Yue Lan Yin, Chun Dang, Yaoheng Lu, Lei Li, Jianguang Ji, Kuikun Yang, Lihua Wang et al. · 2024 · Brain‐X
55. Regulation of miRNA in Cytokine Storm (CS) of COVID‐19 and Other Viral Infection: An Exhaustive Review
    Chiranjib Chakraborty, Manojit Bhattacharya, Arpita Das, Abinit Saha · 2025 · Reviews in Medical Virology
56. Inflammation, abdominal aortic aneurysm enlargement and rupture. Lessons learned from the Covid19 pandemic
    Antonio V. Sterpetti, Francesca Miceli, Alessia Di Girolamo, Antonio Bozzani, Vittorio Arici, Marta Ascione, Luca di Marzo · 2025 · Current Problems in Cardiology
57. Transcriptome analysis of primary chicken cells infected with infectious bronchitis virus strain K047-12 isolated in Korea
    Rangyeon Lee, Ji Seung Jung, Ji-in Yeo, Hyuk Moo Kwon, Jeongho Park · 2021 · Archives of Virology
58. An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction
    Shahab Falahi, Maryam Maleki, Azra Kenarkoohi · 2022 · Infectious Disorders - Drug Targets
59. T-Cell Immune Responses and Immunological Factors Associated with Coronavirus Disease 2019 Progression as Predictors for the Severity of the Disease in Hospitalized Patients
    Tannaz Abbasi-Dokht, Arefe Vafaeinezhad, Negin Khalesi, Farhad Malek, Dariush Haghmorad, Rasoul Baharlou · 2023 · International Archives of Allergy and Immunology
60. Aripiprazole as protector against COVID-19 mortality
    Carlos Loucera, Manuel Canal‐Rivero, Miguel Ruíz-Veguilla, Rosario Carmona, Gerrit Bostelmann, Nathalia Garrido Torres, Joaquı́n Dopazo, Benedicto Crespo‐Facorro · 2024 · Scientific Reports
61. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities
    Modjtaba Emadi‐Baygi, Mahsa Ehsanifard, Najmeh Afrashtehpour, Mahnaz Norouzi, Zahra Joz-Abbasalian · 2021 · Frontiers in Immunology
62. Interleukin-6 Test Strip Combined With a Spectrum-Based Optical Reader for Early Recognition of COVID-19 Patients With Risk of Respiratory Failure
    Yung-Chih Wang, Sheng-Wen Lin, I‐Jen Wang, Chung‐Yao Yang, Chitsung Hong, Jun‐Ren Sun, Po‐Hao Feng, Mei-Hui Lee, Ching‐Fen Shen, Yi‐Tzu Lee et al. · 2022 · Frontiers in Bioengineering and Biotechnology
63. Molecular Docking Analysis from Bryophyllum pinnatum Compound as A COVID-19 Cytokine Storm Therapy
    Perdana Aditya Rahman, Mokhamad Fahmi Rizki Syaban, Salsabila Ghina Anoraga, Faradilah Lukmana Sabila · 2022 · Open Access Macedonian Journal of Medical Sciences
64. Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients
    Marijana Mikačić, Marko Kumrić, Martina Baricevic, Daria Tokić, Sanda Stojanović Stipić, Ivan Cvitković, Daniela Šupe‐Domić, Tina Tičinović Kurir, Joško Božić · 2022 · Journal of Clinical Medicine
65. Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment
    Hamid Chegni, Hadise Babaii, Zuhair M Hassan, M. Pourshaban · 2022 · European Journal of Inflammation
66. Mucosal Immunity After Novel COVID-19 Infection – Virus-Induced Immunosuppression: Preliminary Study
    Elena V. Agafonova, И. Д. Решетникова, Ризванова Фарида Фаритовна · 2022 · BioNanoScience
67. Ageing impairs the airway epithelium defence response to SARS-CoV-2
    Alexander Capraro, Sharon L. Wong, Anurag Adhikari, Katelin M. Allan, Hardip R. Patel, Ling Zhong, Mark J. Raftery, Adam Jaffé, Malinna Yeang, Anupriya Aggarwal et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
68. Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
    Fatma Abd-elkader Moharram, Reham R. Ibrahim, Shahenda Mahgoub, Mohamed Sayed Abdel-aziz, Ahmed Mohammed Said, Hui‐Chi Huang, Lo-Yun Chen, Kuei-Hung Lai, Nashwa Hashad, Mohamed S. Mady · 2025 · PLoS ONE
69. T Cell Dynamics in COVID-19, Long COVID and Successful Recovery
    Zoia R. Korobova, Natalia A. Arsentieva, Anastasia A. Butenko, Игорь Владимирович Кудрявцев, Artem Rubinstein, Anastasia S. Turenko, Yu. V. Ostankova, Ekaterina V. Boeva, Anastasia A. Knizhnikova, Anna O. Norka et al. · 2025 · International Journal of Molecular Sciences
70. Inhaled heparin: Past, present, and future
    Zhewei Liu, Yuqing Ye, Ying Ma, Binjie Hu, Jesse Zhu · 2024 · Drug Discovery Today
71. Critical appraisal of the “cytokine storm” concept in new coronavirus disease COVID-19. Review
    S. S. Bobkova, A. A. Zhukov, Проценко Денис Николаевич, Самойленко Валерий Вячеславович, I. N. Tyurin · 2021 · Annals of critical care
72. Pathogenesis of the initial stages of severe COVID-19
    Александр Сергеевич Голота, Тatyana A. Kamilova, Olga V. Shneider, Dmitry A. Vologzhanin, Sergey G. Sherbak · 2021 · Journal of clinical practice
73. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls
    Ali Mert, Haluk Vahaboğlu, Ferhat Arslan, Ayşe Alga Batırel, Kemal Tolga Saraçoğlu, Aliye Baştuğ, Atahan Çağatay, İlim Irmak, Gülçin Telli Dizman, İhsan Ertenli et al. · 2021 · Rheumatology International
74. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
    Aidan M. Kirkham, Madeline Monaghan, Adrian Joseph-Michel Bailey, Risa Shorr, Manoj Mathew Lalu, Dean A. Fergusson, David Allan · 2021 · Systematic Reviews
75. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID‐19
    Aliyu Idris Muhammad, Gilead Ebiegberi Forcados, Hadiza Sani, Uche Samuel Ndidi, Auwal Adamu, Babangida Sanusi Katsayal, Idris Zubairu Sadiq, Yakubu Saddeeq Abubakar, Ibrahim Sulaiman, Ibrahim Babangida Abubakar et al. · 2022 · Journal of Food Biochemistry
76. Clinical and Spatial Characteristics of Severe Acute Respiratory Syndrome by COVID-19 in Indigenous of Brazil
    Daniele Melo Sardinha, Karla Valéria Batista Lima, Ana Lúcia da Silva Ferreira, Juliana Conceição Dias Garcez, Thalyta MRL Ueno, Yan Corrêa Rodrigues, Anderson Lineu Siqueira dos Santos, Rosane do Socorro Pompeu de Loiola, Ricardo José de Paula Souza e Guimarães, Luana Nepomuceno Gondim Costa Lima · 2021 · Advances in Infectious Diseases
77. Fluctuations in Interleukin-6 Levels during Hemodialysis Sessions with Medium Cutoff Membranes: An Analysis on COVID-19 Case Series
    Ahmet Murt, Serkan Feyyaz Yalın, Dildar Konukoğlu, Claudio Ronco, Mehmet Rıza Altıparmak · 2022 · Blood Purification
78. Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy
    Аnna Lebedeva, Ivan A. Molodtsov, Alexandra Anisimova, Anastasia Berestovskaya, Oleg Dukhin, Antonina Elizarova, Wendy Fitzgerald, Daria S. Fomina, Kseniya A. Glebova, Oxana Ivanova et al. · 2022 · International Journal of Molecular Sciences
79. Latent class analysis: an innovative approach for identification of clinical and laboratory markers of disease severity among COVID-19 patients admitted to the intensive care unit
    Lovemore Nyasha Sigwadhi, Jacques Lukenze Tamuzi, Annalise E. Zemlin, Zivanai Cuthbert Chapanduka, Brian Allwood, Coenraad F.N. Koegelenberg, Elvis M. Irusen, Usha Lalla, Veranyuy Ngah, Anteneh Yalew et al. · 2022 · IJID Regions
80. Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study
    Bruno Märkl, Sebastian Dintner, Tina Schaller, Éva Sipos, Elisabeth Kling, Silvia Miller, Francisco Lopez, Przemyslaw Grochowski, Nic Gabriel Reitsam, Johanna Waidhauser et al. · 2022 · International Journal of Infectious Diseases
81. Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints
    Oksana O. Shevchuk, Svitlana M. Palii, Anastasiia Pak, Nuria Chantada, Nuria Seoane, Mykhaylo M. Korda, Manuel Campos‐Toimil, Ezequiel Álvarez · 2023 · Cells
82. Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
    Agnes Carolin, Kexin Yan, Cameron Bishop, Bing Tang, Wilson Nguyen, Daniel J. Rawle, Andreas Suhrbier · 2024 · PLoS ONE
83. A dossier on COVID-19 chronicle
    Rufaida Rufaida, Tarique Mahmood, Ismail Kedwai, Farogh Ahsan, Arshiya Shamim, Mohammad Shariq, Saba Parveen · 2021 · Journal of Basic and Clinical Physiology and Pharmacology
84. Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlations
    Austin Varela, Sammy Cheng, John H. Werren · 2021 · PeerJ
85. Actualización de la Declaración de consenso en medicina critica para la atención multidisciplinaria del paciente con sospecha o confirmación diagnóstica de COVID-19
    J.L. Mendoza, Víctor Hugo Nieto Estrada, Nelly Beltrán López, Elisabeth Ramos Bolaños, Daniel Molano Franco, Carmelo Rafael Dueñas Castell, Albert Alexander Valencia Moreno, Iván Amaya, John Serna Flórez, BLADIMIR ALEJANDRO GIL VALENCIA et al. · 2020 · Acta Colombiana de Cuidado Intensivo
86. Use of immunology in news and YouTube videos in the context of COVID-19: politicisation and information bubbles
    Rachel Surrage George, Hannah Goodey, Maria Antonietta Russo, Rovena Tula, Pietro Ghezzi · 2024 · Frontiers in Public Health
87. Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study
    Chunyan Li, Hangyong He, Yuqiong Wang, Linna Huang, Ziying Chen, Qi Zhang, Ying Cai, Tianshu Zhai, Xiaojing Wu, Qingyuan Zhan · 2024 · BMC Pulmonary Medicine
88. Complement activity and autophagy are dysregulated in the lungs of patients with nonresolvable COVID-19 requiring lung transplantation
    Pooja Shivshankar, Stacey L. Mueller‐Ortiz, Aleksey Y. Domozhirov, Weizhen Bi, Scott D. Collum, Marie–Françoise Doursout, Manish Kumar Patel, Isabella N. LeFebvre, Bindu H. Akkanti, Simon Yau et al. · 2025 · Respiratory Research
89. Exploring age-related influences on COVID-19 severity and therapeutic approaches for older patients
    Shafaat Hossain, Shaumik Islam, Mohammad Kamruzzaman, Hossain Uddin Shekhar · 2025 · Aging and Health Research
90. Kinetic Profiling in One-Step Digital Immunoassays Enables Multiplex Quantification across an Ultrabroad Dynamic Range
    Abtin Saateh, Rojina Allamehnejad, Wenhong Yang, Yen-Cheng Liu, Genrich V. Tolstonog, Hatice Altug · 2026 · Journal of the American Chemical Society
91. Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19
    Zhicheng Liu, Zhuolei Han, Xin Jin, Jusung An, Jaewon Kim, Wenting Chen, Jong Seung Kim, Ji Zheng, Jun Deng · 2023 · Acta Pharmaceutica Sinica B
92. Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors
    Xinrui Yuan, Hua Jiang, Denggang Fu, Jason C. Rech, Aaron M. Robida, Krishani Kumari Rajanayake, Hebao Yuan, Miao He, Bo Wen, Duxin Sun et al. · 2023 · ACS Pharmacology & Translational Science
93. Immune signature of patients with cardiovascular disease predicts increased risk for a severe course of COVID‐19
    Manina Günter, Karin Anne Lydia Mueller, Mathew J. Salazar, Sarah Gekeler, Carolin Prang, Tobias Harm, Meinrad Gawaz, Stella E. Autenrieth · 2024 · European Journal of Immunology
94. Viral coagulation: pushing the envelope
    Edward L.G. Pryzdial, J. Perrier, Mahamud‐ur Rashid, Henry E. West, Michael R. Sutherland · 2024 · Journal of Thrombosis and Haemostasis
95. Lethal Synergistic Infections by Two Concurrent Respiratory Pathogens
    Kevin Roe · 2024 · Archives of Medical Research
96. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view
    Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh, Krishna Das Saha · 2021 · Life Sciences
97. Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders
    Parniyan Sadeghi, Parmida Sadat Pezeshki, Nima Rezaei · 2023 · European Journal of Pediatrics
98. Redox regulation of defense against bacterial and viral pathogens
    Pietro Ghezzi, Anna Rubartelli · 2023 · Current Opinion in Chemical Biology
99. A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia
    Carlos Pita-Martínez, Felipe Pérez‐García, Ana Virseda‐Berdices, María Martin‐Vicente, Lucía Castilla-García, Irene Hervás Fernández, Victoria González Ventosa, María José Muñoz‐Gómez, Juan Cuadros‐González, Jesús F. Bermejo-Martín et al. · 2023 · International Journal of Infectious Diseases
100. Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy
     Eleonora Russo, Simona Corrao, Francesca Di Gaudio, Giusi Alberti, Martin Čaprnda, Peter Kubatka, Peter Kružliak, Vitale Miceli, Pier Giulio Conaldi, Cesar V. Borlongan et al. · 2023 · Cells